Earnings Preview For Adaptive Biotechnologies
Portfolio Pulse from Benzinga Insights
Adaptive Biotechnologies (NASDAQ:ADPT) is scheduled to release its quarterly earnings report on February 14, 2024, with an expected EPS of $-0.30. Investors are hopeful for a beat on this estimate and positive future guidance. Historically, ADPT's share price has been sensitive to earnings performance and guidance, with significant movements following past earnings announcements. The stock has experienced a 62.71% decline over the last year, trading at $3.92 as of February 12.
February 13, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Adaptive Biotechnologies is expected to report an EPS of $-0.30 for the upcoming quarter. Historical data shows significant stock price movements post-earnings announcements.
Given ADPT's history of stock price volatility post-earnings, the upcoming report could lead to significant short-term price movement. However, the direction of the movement is uncertain and depends on whether the company beats the EPS estimate and provides positive future guidance. The stock's recent performance and historical sensitivity to earnings announcements suggest a neutral score, with high relevance and importance due to the potential impact on investor sentiment.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100